| 000 | 01678 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514161039.0 | ||
| 264 | 0 | _c20031205 | |
| 008 | 200312s 0 0 eng d | ||
| 022 | _a0002-9440 | ||
| 024 | 7 |
_a10.1016/s0002-9440(10)63563-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAhn, Eun-Young | |
| 245 | 0 | 0 |
_aThe combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells. _h[electronic resource] |
| 260 |
_bThe American journal of pathology _cNov 2003 |
||
| 300 |
_a2053-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBH3 Interacting Domain Death Agonist Protein |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCalmodulin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCarrier Proteins _xdrug effects |
| 650 | 0 | 4 | _aCaspase Inhibitors |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCholangiocarcinoma _xmetabolism |
| 650 | 0 | 4 |
_aCytochrome c Group _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_afas Receptor _xgenetics |
| 700 | 1 | _aPan, George | |
| 700 | 1 | _aOh, Jae Hwan | |
| 700 | 1 | _aTytler, Ewan M | |
| 700 | 1 | _aMcDonald, Jay M | |
| 773 | 0 |
_tThe American journal of pathology _gvol. 163 _gno. 5 _gp. 2053-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9440(10)63563-8 _zAvailable from publisher's website |
| 999 |
_c14320021 _d14320021 |
||